Xcelience Makes Structured Cash Investment in Powdersize

TAMPA, Fla., July 31, 2015 /PRNewswire/ -- Xcelience, a contract development and manufacturing organization (CDMO), announced today that it has made a structured cash investment in Powdersize, a Pennsylvania-based company specializing in milling, micronization and powder size classification within the pharmaceutical industry.  This investment will help grow Powdersize's business while simultaneously adding a complete set of particle size control solutions to Xcelience's portfolio of capabilities.

"As we continue to build our suite of services, we are excited to join with Powdersize in an integration that combines their leadership and 23 years of milling and micronizing experience, with our two decades of expertise in drug development," said Derek Hennecke, President and CEO of Xcelience.  "We believe this integration with Powdersize will allow us to deliver greater speed to clinic through exceptional science and extensive capabilities."

Many drugs in pharmaceutical development are poorly soluble.  Reducing particle size through micronization is considered the leading technology for increasing the bioavailability of oral dosage forms when the API has solubility issues.  Current industry trends increasingly demand micronization of APIs with particle sizes of 1-10 micrometers. 

"This collaboration is a natural fit for both sides," says Wayne Sigler, CEO of Powdersize together with partner TJ Higley.  "We fully expect both companies to benefit from each other's strengths and capabilities in drug development and commercial products."  Powdersize will continue with expansion plans in a recently added, state-of-the-art facility, to support the additional business expected with the integration and shared development projects.

"By integrating with Powdersize, we will be able to do more in fewer steps," Mr. Hennecke adds.  "That means faster time to clinic.  It also supports our mission to provide clients with unprecedented levels of innovation and industry-leading expertise to best advance their development and commercial pursuits."

For more information about this press release, please contact Angela Hoffnagle, Marketing Manager, at angela.hoffnagle@xcelience.com or call +1.813.637.6084. 

About Xcelience

Xcelience Suite Science- Xcelience offers a suite of services enabling clients to partner with a single CDMO for all of their global clinical outsourcing needs.  Services include preformulation, analytical services, formulation development, cGMP manufacturing, small-scale commercial manufacturing, and global clinical supplies packaging and logistics.  Xcelience takes pride in delivering the highest standards in science and service with an emphasis on quality, cost and speed.  For more information, visit Xcelience's website at www.xcelience.com or call us at +1.813.286.0404.

About Powdersize

Powdersize is a customer service driven contract manufacturer, providing expertise in particle size reduction and particle size control technologies intended for powders used within the pharmaceutical industry.  With two decades of manufacturing experience, Powdersize can develop a robust process at any scale of development, including R&D, pilot scale or commercial scale.   They combine extensive experience and their unique ability to design custom jet milling systems appropriate for the client's need.  They are one of the leading contract manufacturers offering milling and micronization services in the United States.  Powdersize is located in Quakertown, PA; approximately 1 hour north of Philadelphia.  For more information, visit Powdersize's website at www.powdersize.com.

Contact:
Angie Hoffnagle, Marketing Manager
Xcelience
5415 West Laurel Street
Tampa, FL 33607
Phone: (813) 637.6084
Email: angela.hoffnagle@xcelience.com

Logo - http://photos.prnewswire.com/prnh/20130912/FL78770LOGO

SOURCE Xcelience